Following the success of the previous Challenge-Call on “Advancing Personalised Oncology”, canSERV now invites applications covering the entire range of the oncology developmental pipeline; supporting discoveries in fundamental research to translational science and personalised oncology.
canSERV welcomes excellent research applications addressing at least one of the four strategic goals of the Cancer Mission:
- Understanding of Cancer
- Prevention and Early Detection
- Diagnosis and treatment
- Quality of life for patients and their families
Researchers from academia, industry and SMEs may apply for several services including: i) disease models, ii) cutting-edge imaging and structural biology technologies, iii) biomarker research and development, iv) new therapeutic solutions, v) complex clinical trial design and support, vi) personalised oncology implementation pipelines and recommendations and vii) regulatory support and tools to analyse the socioeconomic dimension of research activities.
Launch of the call: 12 October 2023.
Submission deadline: 4 January 2024, 14:00 (CET) Apply now!
The applications will be reviewed by an international, independent review panel!
The tentative budget for this first call is 1000000 EURO. For more information and the call text, please visit CanSERV’s project website: www.canSERV.eu/Calls
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101058620.
INFRAFRONTIER offers a wide range of in-vivo services within the canSERV project, including the generation of precision cancer models and comprehensive cancer phenotyping, thanks to contributions from 9 INFRAFRONTIER partners.